NCT02446665View on ClinicalTrials.gov

Disease Status in Primary Sclerosing Cholangitis by Elastography

NAActive, not recruitingINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Primary Sclerosing CholangitisElastographyHepatic FibrosisMagnetic Resonance Imaging
Interventions
DEVICE

MR Elastography (MRE) and FibroScan

Trial Locations (1)

M5G 2L7

University Health Network-Princess Margaret Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT02446665 - Disease Status in Primary Sclerosing Cholangitis by Elastography | Biotech Hunter | Biotech Hunter